Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
Loew-Baselli, A
Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. [electronic resource] - Vaccine Jun 2006 - 5256-63 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
0264-410X
10.1016/j.vaccine.2006.03.061 doi
Adolescent
Adult
Aged
Antibodies, Viral--blood
Encephalitis Viruses, Tick-Borne--immunology
Female
Humans
Male
Middle Aged
Single-Blind Method
Vaccination
Viral Vaccines--adverse effects
Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies. [electronic resource] - Vaccine Jun 2006 - 5256-63 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
0264-410X
10.1016/j.vaccine.2006.03.061 doi
Adolescent
Adult
Aged
Antibodies, Viral--blood
Encephalitis Viruses, Tick-Borne--immunology
Female
Humans
Male
Middle Aged
Single-Blind Method
Vaccination
Viral Vaccines--adverse effects